Accretive Health, Inc. Stock Nyse
Equities
US00438V1035
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
||
- USD | - |
05-08 | Health Care Slips as Defensive Investors Rotate to Utilities - Health Care Roundup | DJ |
05-08 | R1 RCM Swings to Loss in Q1, Revenue Rises | MT |
Sales 2024 * | 2.61B 3.57B | Sales 2025 * | 2.92B 3.99B | Capitalization | 5.09B 6.96B |
---|---|---|---|---|---|
Net income 2024 * | -75M -103M | Net income 2025 * | 87M 119M | EV / Sales 2024 * | 2.69 x |
Net Debt 2024 * | 1.93B 2.63B | Net Debt 2025 * | 1.63B 2.22B | EV / Sales 2025 * | 2.3 x |
P/E ratio 2024 * |
-74.7
x | P/E ratio 2025 * |
63.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 35% |
Latest transcript on Accretive Health, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Lee Rivas
CEO | Chief Executive Officer | - | 22-06-21 |
Director of Finance/CFO | - | 22-06-20 | |
John Sparby
PSD | President | 48 | 03-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Tersigni
BRD | Director/Board Member | 74 | 19-08-11 |
David Dill
BRD | Director/Board Member | 55 | 21-04-17 |
Joseph Flanagan
BRD | Director/Board Member | 52 | 13-03-31 |
1st Jan change | Capi. | |
---|---|---|
+17.29% | 85.55B | |
-28.25% | 70.07B | |
+6.76% | 28.95B | |
-7.35% | 17.51B | |
+2.14% | 17.39B | |
+1.81% | 15.38B | |
+6.71% | 13.4B | |
+65.69% | 12.93B | |
+6.64% | 12.77B |